Built for the reader who has to resolve a biopsy before the next case loads onto the scope, this reference connects normal skin histology and a structured pattern-recognition algorithm to the specific calls that decide a patient's treatment path — wide excision or observation, sentinel node biopsy or reassurance, genetics referral or routine follow-up. It moves from foundational pattern analysis through inflammatory dermatoses, infectious and infestation-related disease, epidermal and melanocytic neoplasia, adnexal tumors, and mesenchymal, hematolymphoid, and special-context entities, closing each differential with the same five-step discipline: name the pattern, name its most dangerous mimicker, and resolve the gap with a targeted stain or finding.

Fifty-six worked differentials, evidence-graded management, and a dedicated indexed atlas turn dense criteria into calls you can defend on the record.

From the Punch Biopsy to the Final Call, You Will

• Resolve overlapping inflammatory patterns — distinguish early bullous pemphigoid from spongiotic dermatitis and lichen planus from a lichenoid drug eruption using infiltrate composition and immunofluorescence.
• Grade the melanocytic gray zone — separate severely dysplastic nevus from melanoma in situ and atypical Spitz tumor from Spitzoid melanoma using 9p21 deletion status and kinase fusion testing.
• Clear the trichoepithelioma-versus-basal-cell-carcinoma trap — apply CK20, CD10, and PHLDA1 to a differential that changes the surgical margin.
• Screen sebaceous neoplasms for Muir-Torre syndrome — reflex mismatch repair immunohistochemistry that can catch Lynch syndrome before the first internal malignancy.
• Confirm dermatofibrosarcoma protuberans and patch-stage Kaposi sarcoma — CD34 and HHV-8 criteria that stop a sarcoma or an AIDS-defining lesion from reading as benign.
• Catch patch-stage mycosis fungoides hiding in "eczema" — CD7 loss and clonality findings that end a years-long diagnostic delay.
• Read nail unit melanonychia and scarring alopecia with confidence — MART-1 melanocyte mapping and direct immunofluorescence patterns that separate benign activation and lichen planopilaris from their malignant and lupus-associated mimics.
• Recognize the cutaneous signal of hereditary cancer syndromes — Gorlin, Birt-Hogg-Dubé, and Cowden findings that belong in the report, not just the differential.

Bring it to the microscope — every call in this book is one your next patient is counting on you to get right.